Physician Wealth Advisors’s Gyre Therapeutics GYRE Stock Holding History

Physician Wealth Advisors’s Portfolio GYRE Stock Details GYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$541	Buy	+82	New	+$559	﹤0.01%	2080

Other funds holding GYRE

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

New York State Common Retirement Fund

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Bare Financial Services Gap, Pennsylvania $436M AUM 20.22% 1-Year Est. Return

Physician Wealth Advisors's GYRE Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Gyre Therapeutics (GYRE) in Q2 2026: 82 shares worth $541. The stake represents ﹤0.01% of the portfolio and ranks #2080 among its holdings.

14 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

Physician Wealth Advisors held 82 shares of Gyre Therapeutics worth $541 as of Q2 2026.
Gyre Therapeutics was a new Physician Wealth Advisors position in Q2 2026.
Gyre Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2080 holding.
14 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.